Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit

By Katryna Perera · March 29, 2024, 5:30 PM EDT

A New York federal judge has granted a win to hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a shareholder of biotechnology company Vaxart...

To view the full article, register now.